Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**DimoVena** is a Hungarian over-the-counter topical gel containing **pentosan polysulfate sodium 15 mg/g**, a semisynthetic sulfated polysaccharide with heparinoid, antithrombotic, fibrinolytic, and local anti-inflammatory activity. It is applied for symptoms associated with varicose veins and post-thrombotic venous congestion, superficial thrombophlebitis, venous-leg-ulcer-associated symptoms, tendovaginitis, soft-tissue injuries, hematomas, and scars. The Hungarian product is marketed by Kéri Pharma; its marketing authorization holder and manufacturer are Bene Arzneimittel. ([keripharma.hu](https://www.keripharma.hu/en/our-products/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pentosan polysulfate sodium (bene-Arzneimittel GmbH).